Background
Cancer is best managed by a treatment plan that stays one step ahead of the tumor. However, conventional techniques such as imaging or scans can take more than 3 months to detect whether or not the treatment is working or it has failed. That’s why it is important to determine as quickly as possible if the cancer is responding to the therapy or is progressing. This information is now available through Cancertrack.
Why Cancertrack?
Cancertrack is a non-invasive blood-based investigation that detects circulating tumour cells (CTCs) and cancer-derived biomarkers with ultra-high precision, specificity and reliability. Cancertrack can be used to monitor the disease / recurrence or changes in the tumor characteristics, as often as necessary, without the cost, risk and consequences of radiation from scans, hospitalisation, anaesthesia or painful surgical biopsies.
